3553 results for «2264»

Filter By

3553 results

Rapid-fire abstracts: Session 8

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...

Rapid-fire abstracts: Session 8

Innovations in transcatheter tricuspid valve intervention - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Watch two very innovative tricuspid cases you've never seen before:

  • Part 1: TR replacement
    An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Innovations in transcatheter tricuspid valve intervention

Rapid-fire abstracts: Session 9

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...

Rapid-fire abstracts: Session 9

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

28 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

Maintaining selective coronary access after TAVI and re-do TAVI procedures

28 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.

Maintaining selective

Optimising immediate and long-term outcomes after TAVI

29 Nov 2022 – From PCR London Valves 2022

This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.

Optimising immediate

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Therapy of valvular heart

Reinventing the treatment of patients with tricuspid valve disease

28 Nov 2022 – From PCR London Valves 2022

This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.

Reinventing the treatment

The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair

28 Nov 2022 – From PCR London Valves 2022

Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.

The new PASCAL Precision

TAVI-in-TAVI - A road map for successful lifetime management

29 Nov 2022 – From PCR London Valves 2022

Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.

TAVI-in-TAVI - A road

Transcatheter mitral valve replacement - From planning to final assessment

27 Nov 2022 – From PCR London Valves 2022

In this session, a panel of experts share their experience with transcatheter mitral valve replacement and more specifically new planning and guidance tools using multiple imaging modalities.

Transcatheter mitral

HighLife TSMVR and their latest experiences, moving forward

29 Nov 2022 – From PCR London Valves 2022

A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.

HighLife TSMVR and their

Treating complex coronary lesions: right case right time Prevail™ DCB

01 Oct 2021 – From AICT-AsiaPCR 2021

Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...

Treating complex coronary lesions: right case right time Prevail™ DCB

Telescope guide extension catheter in complex coronary interventions

01 Oct 2021 – From AICT-AsiaPCR 2021

View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.

Telescope guide extension

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

01 Oct 2021 – From AICT-AsiaPCR 2021

In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Renal denervation in the real-world: performance in high risk subgroups

05 Oct 2021 – From AICT-AsiaPCR 2021

After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...

Renal denervation in

Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients

06 Oct 2021 – From AICT-AsiaPCR 2021

In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...

Putting evidence in clinical practice of managing HBR patients
Didn’t find what you were looking for?